Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2025-05-29 00:00:00 ET · period of report 2025-05-28 · accession 0000950170-25-078982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-29 | 2025-05-28 | ANTX | FitzPatrick Margaret M | Dir | P - Purchase | $1.18 | +8,610 | 8,610 | New | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-28 | P | A | 8,610 | $1.18 | 8,610 | D | — | — | (F1) This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. |